Controversy Surrounding Puberty Blockers for Children with Gender Dysphoria
England's National Health Service bans the use of puberty blockers for children seeking treatment for gender dysphoria due to limited research and safety concerns. Research has shown that these blockers can be linked to poor mental health among trans kids. Some European countries exercise caution on using pharmaceutical interventions for children diagnosed with gender dysphoria.
Key Points
- England's NHS has banned the use of puberty blockers for children with gender dysphoria
- European countries like Finland, Norway, and Sweden exercise caution on using pharmaceutical interventions for children with gender dysphoria
- Research has shown that puberty blockers can be linked to poor mental health among trans kids
Cons
- Limited research on the safety and effectiveness of puberty blockers for children with gender dysphoria
- Research has shown a link between puberty blockers and poor mental health among trans kids